The modern healthcare environment is facing an unprecedented call for more tolerable and effective oncology treatments. This surge in Liposomal Doxorubicin Market Demands is primarily rooted in the clinical necessity to treat aggressive malignancies without compromising the patient’s cardiac health. As the global incidence of ovarian cancer and multiple myeloma continues to climb,...